Final Results of the Phase II Study of Rabbit anti-Thymocyte Globulin, Ciclosporin, Methylprednisone, and granulocyte colony-stimulating factor in Patients with Aplastic Anaemia and Myelodysplastic Syndrome

類似資料

• Phase II Study of Rabbit Anti-Thymocyte Globulin, Cyclosporine, and Granulocyte Colony Stimulating Factor in Patients with Aplastic Anemia and Myelodysplastic Syndrome
  著者:: Garg, Ravin, 等
  出版事項: (2009)
• Addition of Eltrombopag to Immunosuppressive Therapy in Patients with Newly Diagnosed Aplastic Anemia
  著者:: Assi, Rita, 等
  出版事項: (2018)
• Phase I-II Study of Bendamustine in Patients With Acute Leukemia and High Risk Myelodysplastic Syndrome
  著者:: Chacar, Christelle, 等
  出版事項: (2012)
• Phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in patients with low or intermediate-1 risk myelodysplastic syndrome
  著者:: Dimicoli, Sophie, 等
  出版事項: (2011)
• Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers
  著者:: Naqvi, Kiran, 等
  出版事項: (2011)